These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 3922531)

  • 1. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
    Nilsson IM; Ljungnér H; Tengborn L
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
    Nguyen G; Horellou MH; Kruithof EK; Conard J; Samama MM
    Blood; 1988 Aug; 72(2):601-5. PubMed ID: 3135860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the fibrinolytic system in deep vein thrombosis.
    Wiman B; Ljungberg B; Chmielewska J; Urdén G; Blombäck M; Johnsson H
    J Lab Clin Med; 1985 Feb; 105(2):265-70. PubMed ID: 3919125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis after hip replacement. Relationship to the fibrinolytic system.
    Eriksson BI; Eriksson E; Gyzander E; Teger-Nilsson AC; Risberg B
    Acta Orthop Scand; 1989 Apr; 60(2):159-63. PubMed ID: 2471386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
    Stalder M; Hauert J; Bachmann F
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
    Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F
    Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.
    Hashimoto Y; Kobayashi A; Yamazaki N; Sugawara Y; Takada Y; Takada A
    Thromb Res; 1987 Jun; 46(5):625-33. PubMed ID: 3114907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura.
    Glas-Greenwalt P; Hall JM; Panke TW; Kant KS; Allen CM; Pollak VE
    J Lab Clin Med; 1986 Nov; 108(5):415-22. PubMed ID: 2430036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
    Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between preoperative status of the fibrinolytic system and occurrence of deep vein thrombosis after major abdominal surgery.
    Mellbring G; Dahlgren S; Wiman B; Sunnegårdh O
    Thromb Res; 1985 Jul; 39(2):157-63. PubMed ID: 2411000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.
    Levi M; Lensing AW; Büller HR; Prandoni P; Dooijewaard G; Cuppini S; ten Cate JW
    Thromb Haemost; 1991 Oct; 66(4):426-9. PubMed ID: 1796391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External pneumatic compression and fibrinolysis in abdominal surgery.
    Cahan MA; Hanna DJ; Wiley LA; Cox DK; Killewich LA
    J Vasc Surg; 2000 Sep; 32(3):537-43. PubMed ID: 10957661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia].
    Astedt B; Fagner U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas.
    Kirchheimer JC; Huber K; Wagner O; Binder BR
    Br J Haematol; 1987 May; 66(1):85-9. PubMed ID: 3109463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB; McGehee WG; Feinstein DI
    Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms.
    Aitchison R; Chu P; Cater DR; Harris RJ; Powell RJ
    Ann Rheum Dis; 1989 Jul; 48(7):590-3. PubMed ID: 2505697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis.
    Jørgensen M; Bonnevie-Nielsen V
    Br J Haematol; 1987 Feb; 65(2):175-80. PubMed ID: 3103670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.